Cerebral malformations are 1 of the many possible causes of cerebral palsy. In this study, a population-based comprehensive cerebral palsy registry was used to identify children whose cerebral palsy could be attributed to a cerebral malformation. The clinical features of these children were then compared with other children with cerebral palsy. Children with cerebral palsy and cerebral malformation did not differ from those without in terms of the neurological subtype of cerebral palsy or its functional severity as measured by the Gross Motor Function Classification System. There was a difference in the number of cumulative comorbidities experienced by the children with cerebral malformation. In addition, children with cerebral malformation tended to be of greater gestational age and birth weight, or the product of a twin gestation. Children with cerebral palsy attributable to a cerebral malformation represent a distinct clinical pathologic entity with respect to predisposing clinical features and associated comorbidities.
Rosenbaum P. , Paneth N., Leviton A., et al. A report: the definition and classification of cerebral palsy. Dev Med Child Neurol. 2007 ; 49(Supp1 2):8-14.
3.
Stanley FJ, Blair E, Alberman E, eds. Cerebral palsies: epidemiology and causal pathways. In: Clinics and Developmental Medicine, No. 151. London: MacKeith Press; 2000:40-108.
4.
O’Shea TMDiagnosis, treatment, and prevention of cerebral palsy. Clin Obstet Gynecol. 2008;51:816-828.
5.
Bax M., Goldstein M., Rosenbaum P., et al. Proposed definition and classification of cerebral palsy. Dev Med Child Neurol. 2005;47: 571-576.
6.
Rosenbaum P. , Leviton A.Cerebral palsy. N Engl J Med . 1994; 330:188-195.
Shevell MI, Majnemer A., Poulin C., et al. Stability of motor impairment in children with cerebral palsy . Dev Med Child Neurol. 2008;50:211-215.
9.
Badawi N., Watson L., Petterson B., et al. What constitutes cerebral palsy? Dev Med Child Neurol. 1998;40:520-527.
10.
Beers MHThe Merck Manual of Medical Information. 2nd ed. Whitehouse Station, NJ: Merck Research Laboratories; 2003: 1624-1626.
11.
Shevell MI, Dagenais L., Hall N., Repacq Consortium.The relationship of cerebral palsy sub-type and functional motor impairment: a population based study. Dev Med Child Neurol. 2009;51:872-877.
12.
Shevell MI, Dagenais L., Hall N., et al. Co-morbidities in cerebral palsy and their relationship to neurologic subtype and GMFCS level. Neurology. 2009;72:2090-2096.
13.
Dagenais L. , Hall N., Majnemer A., et al. Communicating a diagnosis of cerebral palsy: caregiver satisfaction and stress. J Pediatr Neurol . 2006;35:408-414.
14.
Wood E., Rosenbaum P.The gross motor function classification system for cerebral palsy: a study of reliability and stability over time. Dev Med Child Neurol . 2000;42:292-296.
15.
Palisano R. , Hanna S., Rosenbaum P., et al. Validation of a model of gross motor function for children with cerebral palsy. Phys Ther. 2000;80:974-985.
16.
Palisano R. , Cameron D., Rosenbaum PL, Walter SD, Russell D.Stability of the gross motor function system . Dev Med Child Neurol. 2006;48:424-428.
17.
Palisano R. , Rosenbaum P., Walter S., et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol . 1997;39: 214-223.
18.
Rosenbaum LP , Palisano RJ, Bartlett DJ, Galuppi BE, Russell DJDevelopment of the gross motor function classification system for cerebral palsy. Dev Med Child Neurol . 2008;50: 249-253.
19.
Rice J., Russo R., Halbert J., Van Essen P., Haan E.Motor function in 5-year-old children with cerebral palsy in South Australian population. Dev Med Child Neurol. 2009;51:551-556.
20.
Himmelmann K., Beckung E., Hagberg G., Uvebrant P.Gross and fine motor function and accompanying impairments in cerebral palsy. Dev Med Child Neurol. 2006;48:417-423.
21.
Kumar V., Abbas AK, Fausto N., Robbins SL, Cotran RS In: Robbins and Cotran Pathologic Basis of Disease. 8th ed. Philadelphia, PA: Saunders /Elsevier; 2004:1279-1344.
22.
Pinto-Martin JA, Riolo S., Cnaan A., et al. Cranial ultrasound prediction of disabling and nondisabling cerebral palsy at age two in a low birth weight population . J Pediatr. 1995 ;95:249-254.
23.
Inder TE, Wells SJ, Mogridge NB, Spencer C., Volpe JJDefining the nature of the cerebral abnormalities in the premature infant: a qualitative magnetic resonance imaging study. J Pediatr . 2003; 143:171-179.
24.
Walstab JE, Bell RJ, Reddihough DS, Brennecke SP, Bessell CK, Beischer NAFactors identified during the neonatal period associated with risk of cerebral palsy. Aust N Z J Obstet Gynaecol. 2004;44:342-346.
25.
Nelson KBThe epidemiology of cerebral palsy in term infants. Ment Retard Dev Disabil Res Rev. 2002;8:746-750.
26.
Krageloh-Mann I., Horber V.The role of magnetic resonance imaging in elucidating the pathogenesis of cerebral palsy: a systematic review . Dev Med Child Neurol. 2007;49:144-151.
27.
Dammann O., Leviton A.Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res. 1997;42:1-8.
28.
Dammann O., Leviton A.2000. Brain damage in preterm newborns: biological response modification as a strategy to reduce disabilities. J Pediatr.2000;136:433-438.
29.
Edwards AD, Tan S.Perinatal infections, prematurity and brain injury. Curr Opin Pediatr. 2006;18:119-124.
30.
Debillon T. , Gras-Leguen C., Leroy S., et al. Patterns of cerebral inflammatory response in a rabbit model of intrauterine infection-mediated brain lesion . Dev Brain Res. 2003;145:39-48.
31.
Gilles FH, Leviton A., Kerr CSEndotoxin leucoencephalopathy in the telencephalon of the newborn kitten. J Neurol Sci. 1976; 27:183-191.
